On Monday, an Oklahoma judge ruled against Johnson & Johnson and its subsidiaries in a landmark opioid case. The judge fined the drugmaker $572 million to help abate the state's opioid problem in the coming years. In response, Johnson & Johnson and its Janssen Pharmaceutical Companies announced they would appeal the civil judgment, stating it "is confident it has
strong grounds to appeal this decision." Alexis Keenan breaks down the decision on The Final Round.